Bruno Braga Montezano
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Bruno Braga Montezano has a total of 104 co-authors. Here are the top co-authors by number of shared publications:
- Ives Cavalcante Passos
Laboratory of Molecular Psychiatry, Centro de Pesquisa Experimental (CPE) and Centro de Pesquisa Clínica (CPC) Hospital de Clínicas de Porto Alegre (HCPA) Porto Alegre RS Brazil
9 shared publications Luciano Dias de Mattos Souza
Graduate Program in Health and Behavior, Catholic University of Pelotas, Pelotas, RS, Brazil
7 shared publicationsRicardo Azevedo da Silva
Graduate Program in Health and Behavior, Catholic University of Pelotas, Pelotas, RS, Brazil
7 shared publications- Karen Jansen
Graduate Program in Health and Behavior, Catholic University of Pelotas
6 shared publications Karen Jansen
Graduate Program in Health and Behavior, Catholic University of Pelotas, Pelotas, RS, Brazil
5 shared publications- Kyara Rodrigues de Aguiar
Laboratory of Molecular Psychiatry, Centro de Pesquisa Experimental (CPE) and Centro de Pesquisa Clínica (CPC), Hospital de Clínicas de Porto Alegre (HCPA), Porto Alegre, RS, Brazil. Universidade Federal do Rio Grande do Sul, School of Medicine, Graduate Program in Psychiatry and Behavioral Sciences, Department of Psychiatry, Porto Alegre, RS, Brazil
5 shared publications
Latest Publications
- Open Access
- 20 October 2026
- Published by Wiley in Acta Psychiatrica Scandinavica
Bipolar Disorder and the Risk of Cardiovascular Diseases: A Systematic Review and Meta‐Analysis of Observational Studies
Introduction: Bipolar disorder (BD) is a chronic psychiatric illness characterized by recurrent manic and depressive episodes, affecting 2% of the global population. It is associated with premature mortality, including cardiovascular disease (CVD)‐related mortality. Although clinically important, the absolute burden and incidence of cardiovascular outcomes in BD remain incompletely characterized. This systematic review and meta‐analysis synthesized observational evidence on CVD prevalence and incidence in adults with BD. Methods: Following PRISMA guidelines and prospectively registered in PROSPERO (CRD42023484712), we searched PubMed, Web of Science, Embase, Scopus, and PsycInfo, screening 11,909 records. Thirty‐two observational studies in adults with BD were included after Newcastle–Ottawa Scale assessment. Data were extracted on overall CVD, coronary artery disease, cerebrovascular disease, peripheral arterial disease, comorbidities, and psychotropic exposure. Pooled prevalence and incidence rate ratios were calculated using random‐effects models when data were comparable. Results: The pooled CVD prevalence in BD was 7.70% (95% CI: 5.07–11.52), with coronary artery disease at 6.89% (95% CI: 4.05–11.47), cerebrovascular disease at 4.45% (95% CI: 2.13–9.05), and peripheral arterial disease at 3.30% (95% CI: 1.66–6.45). However, prevalence estimates showed extreme heterogeneity and should be interpreted as broad indicators of absolute burden rather than precise estimates for a single BD population. In controlled incidence studies, BD was associated with increased CVD incidence (IRR 1.66, 95% CI: 1.32–2.08), with elevated coronary and cerebrovascular estimates. Clinical variable analyses involving medication use, lifestyle factors, and cardiometabolic comorbidities were not feasible because reporting was insufficient and noncomparable. Conclusion: Adults with BD show substantial cardiovascular burden and increased incidence. However, extreme heterogeneity, limited incidence data, observational designs, and insufficient moderator reporting limit the precision and generalizability of pooled estimates. These findings support integrated cardiovascular screening in BD populations and future prospective studies. Trail Registration: PROSPERO CRD42023484712
- 20 October 2026
- Published by Wiley in Acta Psychiatrica Scandinavica
Open AccessBipolar Disorder and the Risk of Cardiovascular Diseases: A Systematic Review and Meta‐Analysis of Observational Studies
Introduction: Bipolar disorder (BD) is a chronic psychiatric illness characterized by recurrent manic and depressive episodes, affecting 2% of the global population. It is associated with premature mortality, including cardiovascular disease (CVD)‐related mortality. Although clinically important, the absolute burden and incidence of cardiovascular outcomes in BD remain incompletely characterized. This systematic review and meta‐analysis synthesized observational evidence on CVD prevalence and incidence in adults with BD. Methods: Following PRISMA guidelines and prospectively registered in PROSPERO (CRD42023484712), we searched PubMed, Web of Science, Embase, Scopus, and PsycInfo, screening 11,909 records. Thirty‐two observational studies in adults with BD were included after Newcastle–Ottawa Scale assessment. Data were extracted on overall CVD, coronary artery disease, cerebrovascular disease, peripheral arterial disease, comorbidities, and psychotropic exposure. Pooled prevalence and incidence rate ratios were calculated using random‐effects models when data were comparable. Results: The pooled CVD prevalence in BD was 7.70% (95% CI: 5.07–11.52), with coronary artery disease at 6.89% (95% CI: 4.05–11.47), cerebrovascular disease at 4.45% (95% CI: 2.13–9.05), and peripheral arterial disease at 3.30% (95% CI: 1.66–6.45). However, prevalence estimates showed extreme heterogeneity and should be interpreted as broad indicators of absolute burden rather than precise estimates for a single BD population. In controlled incidence studies, BD was associated with increased CVD incidence (IRR 1.66, 95% CI: 1.32–2.08), with elevated coronary and cerebrovascular estimates. Clinical variable analyses involving medication use, lifestyle factors, and cardiometabolic comorbidities were not feasible because reporting was insufficient and noncomparable. Conclusion: Adults with BD show substantial cardiovascular burden and increased incidence. However, extreme heterogeneity, limited incidence data, observational designs, and insufficient moderator reporting limit the precision and generalizability of pooled estimates. These findings support integrated cardiovascular screening in BD populations and future prospective studies. Trail Registration: PROSPERO CRD42023484712
- 16 November 2025
- Published by Springer Nature
- p. 41-52
Diagnostic Conversion from Major Depressive Disorder to Bipolar Disorder
- 16 November 2025
- Published by Springer Nature
- p. 41-52
Diagnostic Conversion from Major Depressive Disorder to Bipolar Disorder
- Open Access
- 1 January 2025
- Published by EDITORA SCIENTIFIC in Trends in Psychiatry and Psychotherapy
- Vol. 47 (AheadOfPri)
Digital interventions for depressive symptoms: a randomized clinical trial
Trends Psychiatry Psychother, vol.0, nAheadOfPrint, p.0-0, 2025
- 1 January 2025
- Published by EDITORA SCIENTIFIC in Trends in Psychiatry and Psychotherapy
- Vol. 47 (AheadOfPri)
Open AccessDigital interventions for depressive symptoms: a randomized clinical trial
Trends Psychiatry Psychother, vol.0, nAheadOfPrint, p.0-0, 2025
- Open Access
- 1 January 2025
- Published by EDITORA SCIENTIFIC in Trends in Psychiatry and Psychotherapy
- Vol. 47 (AheadOfPri)
Exploring protective factors in a high-risk subsample: the pivotal role of paternal support in preventing depression in a cohort of young adults
Trends Psychiatry Psychother, vol.0, nAheadOfPrint, p.0-0, 2024
- 1 January 2025
- Published by EDITORA SCIENTIFIC in Trends in Psychiatry and Psychotherapy
- Vol. 47 (AheadOfPri)
Open AccessExploring protective factors in a high-risk subsample: the pivotal role of paternal support in preventing depression in a cohort of young adults
Trends Psychiatry Psychother, vol.0, nAheadOfPrint, p.0-0, 2024
- 10 November 2024
- Published by Elsevier in Journal of Psychiatric Research
- Vol. 180, 482-488
Clinical and lifestyle predictors of loneliness: A two-year longitudinal study
- 10 November 2024
- Published by Elsevier in Journal of Psychiatric Research
- Vol. 180, 482-488
Clinical and lifestyle predictors of loneliness: A two-year longitudinal study
- 21 April 2024
- Published by Elsevier in Psychiatry Research
- Vol. 337, 115915
Subcutaneous ketamine reduces suicide risk and improves functioning in depression: A proof-of-concept study
- 21 April 2024
- Published by Elsevier in Psychiatry Research
- Vol. 337, 115915
Subcutaneous ketamine reduces suicide risk and improves functioning in depression: A proof-of-concept study
- Top Cited PapersOpen Access
- 15 April 2024
- Published by Elsevier in Jornal de Pediatria
- Vol. 100 (6) , 565-585
The role of parental stress on emotional and behavioral problems in offspring: a systematic review with meta-analysis
- 15 April 2024
- Published by Elsevier in Jornal de Pediatria
- Vol. 100 (6) , 565-585
Top Cited PapersOpen AccessThe role of parental stress on emotional and behavioral problems in offspring: a systematic review with meta-analysis
- Open Access
- 30 March 2024
- Published by JMIR Publications Inc. in JMIR Preprints
Predictors of response to a single session intervention to reduce emotional distress using of Enhanced Psychoeducation among professionals from essential services during the COVID-19 pandemic (Preprint)
BACKGROUND Single session intervention (SSI) have been shown to be an effective strategy for reducing emotional distress. Enhanced psychoeducation (EP), which includes empathic listening, risk stratification, symptom monitoring, and habit modification, is particularly suitable for SSIs. OBJECTIVE This study aimed to investigate the predictors of responses to an online EP intervention among professionals from essential services during the COVID19 in Brazil with the aim of reducing emotional distress. METHODS This study analyzed data from the TELEPSI Project from April 2020 to December 2021. We included all participants who received SSIs with high levels of emotional distress (T-scores above 70 on the PROMIS for anxiety, depression, or irritability). RESULTS The final sample consisted of 460 subjects, 89.1% female and 81.1% health professionals, of which 300 subjects underwent reassessment in one month (65% retention). Participants with harmful use of social networks, spending time on social media, playing video games, smoking, drinking alcohol, using drugs, and spending time with pets showed a less pronounced decrease in symptoms. In contrast, participants who played instruments or had already received psychological treatment showed a greater magnitude of decrease in symptoms. CONCLUSIONS This study highlights the impact of lifestyle factors on SSI efficacy. These results underscore the importance of considering individual lifestyle factors when implementing SSIs, and contribute to a growing body of evidence supporting the tailored application of psychoeducational strategies in mental health interventions, particularly in high-stress environments.
- 30 March 2024
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessPredictors of response to a single session intervention to reduce emotional distress using of Enhanced Psychoeducation among professionals from essential services during the COVID-19 pandemic (Preprint)
BACKGROUND Single session intervention (SSI) have been shown to be an effective strategy for reducing emotional distress. Enhanced psychoeducation (EP), which includes empathic listening, risk stratification, symptom monitoring, and habit modification, is particularly suitable for SSIs. OBJECTIVE This study aimed to investigate the predictors of responses to an online EP intervention among professionals from essential services during the COVID19 in Brazil with the aim of reducing emotional distress. METHODS This study analyzed data from the TELEPSI Project from April 2020 to December 2021. We included all participants who received SSIs with high levels of emotional distress (T-scores above 70 on the PROMIS for anxiety, depression, or irritability). RESULTS The final sample consisted of 460 subjects, 89.1% female and 81.1% health professionals, of which 300 subjects underwent reassessment in one month (65% retention). Participants with harmful use of social networks, spending time on social media, playing video games, smoking, drinking alcohol, using drugs, and spending time with pets showed a less pronounced decrease in symptoms. In contrast, participants who played instruments or had already received psychological treatment showed a greater magnitude of decrease in symptoms. CONCLUSIONS This study highlights the impact of lifestyle factors on SSI efficacy. These results underscore the importance of considering individual lifestyle factors when implementing SSIs, and contribute to a growing body of evidence supporting the tailored application of psychoeducational strategies in mental health interventions, particularly in high-stress environments.
- 20 February 2024
- Published by Wiley in Acta Psychiatrica Scandinavica
- Vol. 149 (4) , 340-349
Early exposure to cannabis and bipolar disorder incidence: Findings from a 22‐year birth cohort study in Brazil
Background and Objectives: Bipolar disorder is a chronic condition affecting millions of people worldwide. Currently, there is some evidence to suggest that cannabis use during adolescence may be an environmental risk factor for its onset, however inconsistencies have been observed across the literature. Considering this, we aimed to assess whether early lifetime cannabis is associated with subsequent bipolar disorder in young adults between 18 and 22 years of age.Methods: Using data from the 1993 Pelotas (Brazil) birth cohort (n = 5249), cannabis exposure was examined at age 18 by self‐report, and bipolar disorder diagnosis was measured at age 22 using the Mini International Neuropsychiatric Interview (MINI). In order to control the analysis, we considered socioeconomic status index, sex, skin color, physical abuse by parents and lifetime cocaine use.Results: A total of 3781 individuals were evaluated in 2015 aged 22 years, of whom 87 were diagnosed with the bipolar disorder onset after the age of 18. Lifetime cannabis use predicted bipolar disorder onset at 22 years old (OR 1.82, 95% CI [1.10, 2.93]), and the effect remained after adjusting for socioeconomic status, sex, skin color, and physical abuse by parents (OR 2.00, 95% CI [1.20, 3.25]). However, this association was attenuated to statistically non‐significant after further adjustment for all available covariates, including lifetime cocaine use (OR 1.79, 95% CI [0.95, 3.19]). We also found similar results for early cocaine use, where the association with bipolar disorder onset did not maintain significance in the multivariate model (OR 1.35, 95% CI [0.62, 2.86]). Otherwise, when we considered cannabis or cocaine lifetime use as a unique feature, our findings showed that the adolescent exposure to cannabis or cocaine increased the odds by 1.95 times of developing bipolar disorder at 22 years age, even when controlling for all other study variables (OR 2.14, 95% CI [1.30, 3.47]). Finally, our models suggest that cocaine use may potentially exert a major influence on the effect of lifetime cannabis use on bipolar disorder onset, and that physical abuse by parents and sex may modify the effect of cannabis use for later bipolar disorder onset.Conclusion: Based on our findings, early cannabis exposure predicted bipolar disorder onset in young adults, but this association was confounded by cocaine use. Contrary to schizophrenia, cannabis as a sole exposure was not associated with bipolar disorder onset after adjusting for control variables.
- 20 February 2024
- Published by Wiley in Acta Psychiatrica Scandinavica
- Vol. 149 (4) , 340-349
Early exposure to cannabis and bipolar disorder incidence: Findings from a 22‐year birth cohort study in Brazil
Background and Objectives: Bipolar disorder is a chronic condition affecting millions of people worldwide. Currently, there is some evidence to suggest that cannabis use during adolescence may be an environmental risk factor for its onset, however inconsistencies have been observed across the literature. Considering this, we aimed to assess whether early lifetime cannabis is associated with subsequent bipolar disorder in young adults between 18 and 22 years of age.Methods: Using data from the 1993 Pelotas (Brazil) birth cohort (n = 5249), cannabis exposure was examined at age 18 by self‐report, and bipolar disorder diagnosis was measured at age 22 using the Mini International Neuropsychiatric Interview (MINI). In order to control the analysis, we considered socioeconomic status index, sex, skin color, physical abuse by parents and lifetime cocaine use.Results: A total of 3781 individuals were evaluated in 2015 aged 22 years, of whom 87 were diagnosed with the bipolar disorder onset after the age of 18. Lifetime cannabis use predicted bipolar disorder onset at 22 years old (OR 1.82, 95% CI [1.10, 2.93]), and the effect remained after adjusting for socioeconomic status, sex, skin color, and physical abuse by parents (OR 2.00, 95% CI [1.20, 3.25]). However, this association was attenuated to statistically non‐significant after further adjustment for all available covariates, including lifetime cocaine use (OR 1.79, 95% CI [0.95, 3.19]). We also found similar results for early cocaine use, where the association with bipolar disorder onset did not maintain significance in the multivariate model (OR 1.35, 95% CI [0.62, 2.86]). Otherwise, when we considered cannabis or cocaine lifetime use as a unique feature, our findings showed that the adolescent exposure to cannabis or cocaine increased the odds by 1.95 times of developing bipolar disorder at 22 years age, even when controlling for all other study variables (OR 2.14, 95% CI [1.30, 3.47]). Finally, our models suggest that cocaine use may potentially exert a major influence on the effect of lifetime cannabis use on bipolar disorder onset, and that physical abuse by parents and sex may modify the effect of cannabis use for later bipolar disorder onset.Conclusion: Based on our findings, early cannabis exposure predicted bipolar disorder onset in young adults, but this association was confounded by cocaine use. Contrary to schizophrenia, cannabis as a sole exposure was not associated with bipolar disorder onset after adjusting for control variables.
- Open Access
- 1 January 2024
- Published by EDITORA SCIENTIFIC in Brazilian Journal of Psychiatry
- Vol. 46, 1-40
Protective factors against depression in high-risk children and adolescents: a systematic review of longitudinal studies
Objective: From a preventive perspective, this study reviewed the literature on protective factors against depressive symptoms in high-risk children and adolescents. Methods: We conducted a thorough search of the PubMed, APA, EMCare, and Embase databases for studies published between 1946 and August 25, 2023. We included only longitudinal studies that analyzed protective factors for depressive symptoms in high-risk children or adolescents, excluding cross-sectional studies, reviews, and pre-clinical studies. Results: A total of 29 studies with 62,405 participants were analyzed and 38 protective factors were identified. Positive individual characteristics, family factors, peer relationships, school-related aspects, neighborhood characteristics, and intrinsic religiosity were associated with improved depression outcomes. Conclusion: These findings have important implications for preventive strategies in this population. Addressing protective factors can help prevent depression and enhance lifetime mental health.
- 1 January 2024
- Published by EDITORA SCIENTIFIC in Brazilian Journal of Psychiatry
- Vol. 46, 1-40
Open AccessProtective factors against depression in high-risk children and adolescents: a systematic review of longitudinal studies
Objective: From a preventive perspective, this study reviewed the literature on protective factors against depressive symptoms in high-risk children and adolescents. Methods: We conducted a thorough search of the PubMed, APA, EMCare, and Embase databases for studies published between 1946 and August 25, 2023. We included only longitudinal studies that analyzed protective factors for depressive symptoms in high-risk children or adolescents, excluding cross-sectional studies, reviews, and pre-clinical studies. Results: A total of 29 studies with 62,405 participants were analyzed and 38 protective factors were identified. Positive individual characteristics, family factors, peer relationships, school-related aspects, neighborhood characteristics, and intrinsic religiosity were associated with improved depression outcomes. Conclusion: These findings have important implications for preventive strategies in this population. Addressing protective factors can help prevent depression and enhance lifetime mental health.